Chemoinformaics analysis of 2,3-Di-O-methyl-L-arabinose
| Molecular Weight | 178.184 | nRot | 6 |
| Heavy Atom Molecular Weight | 164.072 | nRig | 1 |
| Exact Molecular Weight | 178.084 | nRing | 0 |
| Solubility: LogS | 0.413 | nHRing | 0 |
| Solubility: LogP | -1.537 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 12 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 25.0351 |
| nHD | 2 | BPOL | 18.3849 |
| QED | 0.488 |
| Synth | 4.035 |
| Natural Product Likeliness | 1.955 |
| NR-PPAR-gamma | 0.008 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.025 |
| HIA | 0.421 |
| CACO-2 | -4.961 |
| MDCK | 0.000587402 |
| BBB | 0.109 |
| PPB | 0.259498 |
| VDSS | 0.481 |
| FU | 0.773192 |
| CYP1A2-inh | 0.008 |
| CYP1A2-sub | 0.219 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.248 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.032 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.115 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.126 |
| CL | 5.084 |
| T12 | 0.745 |
| hERG | 0.071 |
| Ames | 0.12 |
| ROA | 0.008 |
| SkinSen | 0.721 |
| Carcinogencity | 0.022 |
| EI | 0.952 |
| Respiratory | 0.029 |
| NR-Aromatase | 0.07 |
| Antiviral | No |
| Prediction | 0.931023 |